Biogen Inc (BIIB) - Yalpi foyda bo'yicha sotuv rentabelligi

Biogen Inc (BIIB) kompaniyasining rasmiy ramzlari

Yangi dori vositalarining muvaffaqiyatsizligi va narxlardagi bosim xatarlari noaniqlikni yuzaga keltirmoqda, bu esa qat'iy standartlar ostida zavod operatsiyalarining barqarorligini talab qiladi. Ushbu tendentsiya yalpi foyda ko'rsatkichi orqali aks etgan bo'lib, bunda 64.00 yakuniy daraja belgisi vazifasini o'taydi. Yuqori masshtablanuvchanlik va flakon ishlab chiqarish xarajatlarining pastligi umumiy manzarani to'ldirib, Biogen Inc. (BIIB) kompaniyasining global sotuv potentsialini tasdiqlaydi.

BIIB: Biogen Yalpi marja 04.07.2022 - 19.11.2026

Biogen Inc. (BIIB) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Biogen
Biogen Idec seriyali mahsuloti

Yalpi foyda umumiy daromad va bevosita ishlab chiqarish xarajatlari orasidagi farq sifatida hisoblanadi. Ushbu ko'rsatkich xarajatlarni boshqarish samaradorligini va kompaniyaning fundamental darajada foyda keltirish qobiliyatini belgilaydi. Biogen Inc. (BIIB) uchun yuqori marjalar shakllangan nevrologik kasalliklar terapiyasi ekotizimi doirasidagi noyob dori vositalarining qiymatini tasdiqlaydi. Maqsadli yalpi foyda tendentsiyasini tahlil qilish biznes modelining bozor tebranishlariga chidamliligini baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Corp) - Yalpi marja|AXSM: Yalpi foyda normasi|Yalpi rentabellik acadia-pharm.com (ACAD)|Yalpi marja Xenon Pharmaceuticals (XENE)|Yalpi rentabellik Viking Therapeutics VKTX|Yalpi foyda normasi SUPN|CPRX - Yalpi rentabellik|Yalpi foyda marjasi Denali Therapeutics|HRMY: Yalpi marja|Biohaven - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik AMLX|Trevi Therapeutics, Inc. (TRVI) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik PRAX (Praxis Medicines)|Anavex Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik CeriBell CBLL|Yalpi foyda bo'yicha sotuv rentabelligi Prothena Biosciences (PRTA)|ALEC: Yalpi foyda bo'yicha rentabellik|ANNX - Yalpi marja|Omeros Corp. (OMER) - Yalpi rentabellik|Yalpi foyda marjasi Neurogene Inc. (NGNE)|Yalpi foyda bo'yicha rentabellik ACIU|Yalpi rentabellik VYGR|Yalpi rentabellik Neumora (NMRA)|SCLX - Yalpi foyda marjasi|Yalpi marja TVGN (Tevogen Bio Holdings Inc.)|Yalpi foyda normasi ACOG|Cognition Therapeutics Inc. - Yalpi marja|IKT - Yalpi marja|SAVA: Yalpi marja|Assertio Holdings, Inc. - Yalpi foyda normasi|COYA (Coya) - Yalpi marja|Sotuvning yalpi rentabelligi VTGN (Vistagen Therapeutics)|Yalpi rentabellik Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)